Drug Shortage Report for MULTI 12 INJECTION
| Report ID | 189913 |
| Drug Identification Number | 02100606 |
| Brand name | MULTI 12 INJECTION |
| Common or Proper name | MULTI 12 INJECTION |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | VITAMIN B12 FOLIC ACID BIOTIN VITAMIN E DEXPANTHENOL PYRIDOXINE HYDROCHLORIDE NICOTINAMIDE VITAMIN B2 VITAMIN B1 VITAMIN D VITAMIN A ASCORBIC ACID |
| Strength(s) | 1MCG 80MCG 12MCG 2UNIT 3MG 0.8MG 8MG 0.72MG 0.6MG 40UNIT 660UNIT 20MG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 25ML |
| ATC code | B05XC |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-04-20 |
| Estimated end date | 2023-05-19 |
| Actual end date | 2023-05-01 |
| Shortage status | Resolved |
| Updated date | 2023-05-03 |
| Company comments | Baxter item: 6420 Product under allocation with 50% allocated. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-05-03 | English | Compare |
| v5 | 2023-05-01 | French | Compare |
| v4 | 2023-05-01 | English | Compare |
| v3 | 2023-04-21 | English | Compare |
| v2 | 2023-04-20 | French | Compare |
| v1 | 2023-04-20 | English | Compare |
Showing 1 to 6 of 6